Are there any opportunities to participate in fundraising events for psoriatic arthritis research?

To evaluate efficacy and safety of the anti-interleukin-23p19 monoclonal antibody tildrakizumab in patients with psoriatic arthritis (PsA). Learn about dosing information of STELARA® (ustekinumab) for your patients, including administration information. See full prescribing and safety ... Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Psoriatic Arthritis · Rheumatoid Arthritis. More About Arthritis. Related ... Informational Brochures: Juvenile Arthritis and A Teacher's Guide. Help your ... See Study Documents Below. Study Details. Medical Condition. Medical Condition icon. Psoriatic Arthritis. Study Phase. Study Phase icon. Phase 3. Intervention ... Presents information about plaque, nail, guttate, pustular, inverse and erythrodermic psoriasis. Explains common triggers and the numerous treatments for ... W Taylor, D Gladman, P Helliwell, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Oct 22, 2024 ... This qualitative study explores the perspective of psoriatic arthritis (PsA) patients towards these so-called digital biomarkers (dBMs). SELECT-PsA 2 Biologic DMARD-IR Patient data for RINVOQ 15 mg: 58. In an As Observed (AO) analysis, patients with missing data ... Sep 16, 2020 ... I do have a video series on fasting for hypertension, but what about psoriasis, eczema, type 2 diabetes, lupus, metabolic disorder, rheumatoid ...